HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norio Masumoto Selected Research

Biological Factors

10/2019The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norio Masumoto Research Topics

Disease

27Breast Neoplasms (Breast Cancer)
05/2022 - 11/2011
11Neoplasms (Cancer)
03/2022 - 12/2011
5Triple Negative Breast Neoplasms
05/2022 - 11/2011
3Neoplasm Metastasis (Metastasis)
09/2021 - 09/2014
3Lymphatic Metastasis
11/2019 - 09/2013
2Type 2 Diabetes Mellitus (MODY)
06/2017 - 03/2017
1Microsatellite Instability
03/2022
1Turcot syndrome
03/2022
1Febrile Neutropenia
07/2021
1Pathologic Complete Response
01/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2012
1Shock
09/2012
1Interstitial Lung Diseases (Interstitial Lung Disease)
09/2012
1Sepsis (Septicemia)
09/2012
1Liver Failure
01/2009
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
09/2007

Drug/Important Bio-Agent (IBA)

5Estrogen ReceptorsIBA
09/2021 - 09/2013
5Phenobarbital (Luminal)FDA Link
05/2021 - 02/2015
4ErbB Receptors (EGF Receptor)IBA
05/2022 - 05/2016
4Trastuzumab (Herceptin)FDA Link
07/2021 - 11/2011
4Biological ProductsIBA
05/2021 - 09/2013
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2021 - 04/2015
3human ERBB2 proteinIBA
07/2021 - 09/2013
3AlbuminsIBA
06/2017 - 09/2007
2Pharmaceutical PreparationsIBA
09/2021 - 03/2017
2Paclitaxel (Taxol)FDA LinkGeneric
09/2021 - 04/2015
2Estrogens (Estrogen)FDA Link
09/2021 - 09/2013
2taxaneIBA
01/2018 - 04/2015
2Hormones (Hormone)IBA
04/2015 - 10/2013
1Immune Checkpoint InhibitorsIBA
03/2022
1Biomarkers (Surrogate Marker)IBA
03/2022
1pembrolizumabIBA
03/2022
1TamoxifenFDA LinkGeneric
09/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2021
1Docetaxel (Taxotere)FDA Link
07/2021
1Protein Isoforms (Isoforms)IBA
06/2020
1Culture MediaIBA
06/2020
1RNA (Ribonucleic Acid)IBA
06/2020
1Transfer RNA (tRNA)IBA
06/2020
1MicroRNAs (MicroRNA)IBA
06/2020
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2019
1Biological FactorsIBA
10/2019
1Proteins (Proteins, Gene)FDA Link
04/2018
1Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
04/2018
1AnthracyclinesIBA
01/2018
1alogliptinIBA
06/2017
1Dipeptidyl-Peptidase IV InhibitorsIBA
06/2017
1perfluorobutane (AI 700)IBA
05/2016
1Albumin-Bound PaclitaxelFDA Link
04/2015
1Epirubicin (Ellence)FDA LinkGeneric
04/2015
1Fluorouracil (Carac)FDA LinkGeneric
04/2015
1cremophorIBA
04/2015
1Progesterone Receptors (Progesterone Receptor)IBA
09/2013
1Capecitabine (Xeloda)FDA Link
12/2011
1Plasminogen Activators (Plasminogen Activator)IBA
09/2007
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
09/2007

Therapy/Procedure

7Drug Therapy (Chemotherapy)
03/2022 - 11/2011
5Neoadjuvant Therapy
05/2022 - 04/2016
5Therapeutics
03/2022 - 09/2012
2Glycemic Control
06/2017 - 03/2017
1Mastectomy (Mammectomy)
03/2022
1Adjuvant Chemotherapy
07/2021
1Simple Mastectomy
01/2019
1Lymph Node Excision (Lymph Node Dissection)
09/2014
1Segmental Mastectomy (Lumpectomy)
02/2013
1Aftercare (After-Treatment)
09/2012
1Transplantation
01/2009